Cargando…
TMEM180 contributes to SW480 human colorectal cancer cell proliferation through intra-cellular metabolic pathways
TMEM180, a novel colon cancer–specific protein with a 12-transmembrane topology, is upregulated at low oxygen. Previously, we established a humanized monoclonal antibody against TMEM180 aimed at clinical trials. Prior to such trials, it is necessary to clarify the function of TMEM180 in cancer. To c...
Autores principales: | Anzai, Takahiro, Saijou, Shinji, Ohnuki, Yoshitsugu, Kurosawa, Hiroshi, Yasunaga, Masahiro, Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335657/ https://www.ncbi.nlm.nih.gov/pubmed/34332338 http://dx.doi.org/10.1016/j.tranon.2021.101186 |
Ejemplares similares
-
Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer‐specific molecule
por: Yasunaga, Masahiro, et al.
Publicado: (2019) -
High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
por: Shiraishi, Takuya, et al.
Publicado: (2021) -
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines
por: Anzai, Takahiro, et al.
Publicado: (2022) -
Inhibition of α(1,6)fucosyltransferase: Effects on Cell Proliferation, Migration, and Adhesion in an SW480/SW620 Syngeneic Colorectal Cancer Model
por: López-Cortés, Rubén, et al.
Publicado: (2022) -
Analgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cells
por: GU, YU, et al.
Publicado: (2013)